Literature DB >> 17187179

Uptake of microparticles into the epithelium of human nasopharyngeal lymphoid tissue.

Yoshinori Fujimura1, Takeshi Akisada, Tamotsu Harada, Ken Haruma.   

Abstract

The M cells of nasopharyngeal lymphoid tissue (NALT) have been considered to play an important role for vaccine delivery systems in humans. A number of investigations have reported particle uptake data in NALT of rodents. However, there have been no reports indicating any involvement of the nasopharyngeal lymphoid tissue in human vaccination. In the present study, we investigated whether the epithelium of human adenoid tissues might incorporate fluorescent microparticles using electron and fluorescent microscopy. The dissected adenoid tissues were incubated with various sizes and concentrations of fluorescent microparticles for 120 min at 37 degrees C. Furthermore, the effect of surface coatings of microparticles with cations on the uptake into the epithelium of adenoid tissues was investigated. Transmission electron microscopy revealed that microparticles were taken up by the M cells of human nasopharyngeal lymphoid tissues. The NALT-M cells showed greater uptake of the smallest particles, 0.2 microm in diameter, than those of 0.5, 1.0, or 2.0 microm diameter. It was also revealed that surface coatings with poly-L: -lysin or chitosan resulted in efficient uptake into the NALT. These results indicate that nasal administration of antigenic microparticles, which were coated with cationic materials, probably leads to a useful method of transnasal vaccination against respiratory and intestinal infections in humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17187179     DOI: 10.1007/s00795-006-0335-6

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  18 in total

Review 1.  Chitosan as a novel nasal delivery system for vaccines.

Authors:  L Illum; I Jabbal-Gill; M Hinchcliffe; A N Fisher; S S Davis
Journal:  Adv Drug Deliv Rev       Date:  2001-09-23       Impact factor: 15.470

Review 2.  DNA vaccines.

Authors:  J J Donnelly; J B Ulmer; M A Liu
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

3.  Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins.

Authors:  P J Giannasca; J A Boden; T P Monath
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2).

Authors:  P Artursson; T Lindmark; S S Davis; L Illum
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

5.  Electron-microscope observations on the tonsillar epithelium in children with recurrent tonsillitis.

Authors:  T Karchev; P Kabakchiev
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1982-06       Impact factor: 1.675

6.  Transport of nanoparticles across the rat nasal mucosa.

Authors:  J Brooking; S S Davis; L Illum
Journal:  J Drug Target       Date:  2001       Impact factor: 5.121

7.  Antigen-presenting cells in the hypertrophic pharyngeal tonsils: a histochemical, immunuhistochemical and ultrastructural study.

Authors:  M Kemal Ozbilgin; S Polat; U O Mete; O Tap; M Kaya
Journal:  J Investig Allergol Clin Immunol       Date:  2004       Impact factor: 4.333

8.  Ultrastructural study of M cells from colonic lymphoid nodules obtained by colonoscopic biopsy.

Authors:  Y Fujimura; M Hosobe; T Kihara
Journal:  Dig Dis Sci       Date:  1992-07       Impact factor: 3.199

9.  Tacrolimus (FK506) and cyclosporine reduce the uptake and transport of particles into rabbit Peyer's patches.

Authors:  Yoshinori Fujimura; Robert L Owen
Journal:  Transplantation       Date:  2002-04-15       Impact factor: 4.939

10.  The role of M cells of human nasopharyngeal lymphoid tissue in influenza virus sampling.

Authors:  Yoshinori Fujimura; Masaharu Takeda; Hidenori Ikai; Ken Haruma; Takeshi Akisada; Tamotsu Harada; Tatsuya Sakai; Masanobu Ohuchi
Journal:  Virchows Arch       Date:  2003-10-10       Impact factor: 4.064

View more
  7 in total

1.  Encapsulation of an EP67-Conjugated CTL Peptide Vaccine in Nanoscale Biodegradable Particles Increases the Efficacy of Respiratory Immunization and Affects the Magnitude and Memory Subsets of Vaccine-Generated Mucosal and Systemic CD8+ T Cells in a Diameter-Dependent Manner.

Authors:  Bala V K Karuturi; Shailendra B Tallapaka; Pravin Yeapuri; Stephen M Curran; Sam D Sanderson; Joseph A Vetro
Journal:  Mol Pharm       Date:  2017-04-03       Impact factor: 4.939

2.  Nasal immunity to staphylococcal toxic shock is controlled by the nasopharynx-associated lymphoid tissue.

Authors:  Stefan Fernandez; Emily D Cisney; Shannan I Hall; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2011-02-16

3.  Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery.

Authors:  Thejani E Rajapaksa; Mary Stover-Hamer; Xiomara Fernandez; Holly A Eckelhoefer; David D Lo
Journal:  J Control Release       Date:  2009-11-05       Impact factor: 9.776

4.  Mucosal adjuvant activity of oligomannose-coated liposomes for nasal immunization.

Authors:  Mariko Ishii; Naoya Kojima
Journal:  Glycoconj J       Date:  2009-10-09       Impact factor: 2.916

5.  Expression of tight junction proteins in epithelium including Ck20-positive M-like cells of human adenoids in vivo and in vitro.

Authors:  Ken-ichi Takano; Takashi Kojima; Noriko Ogasawara; Mitsuru Go; Shin Kikuchi; Takafumi Ninomiya; Makoto Kurose; Jun-ichi Koizumi; Ryuta Kamekura; Masaki Murata; Satoshi Tanaka; Hideki Chiba; Tetsuo Himi; Norimasa Sawada
Journal:  J Mol Histol       Date:  2008-02-02       Impact factor: 2.611

6.  Strategies for intranasal delivery of vaccines.

Authors:  Mehfuz Zaman; Saranya Chandrudu; Istvan Toth
Journal:  Drug Deliv Transl Res       Date:  2012-07-12       Impact factor: 4.617

Review 7.  Cellular senescence in lymphoid organs and immunosenescence.

Authors:  Vivekananda Budamagunta; Thomas C Foster; Daohong Zhou
Journal:  Aging (Albany NY)       Date:  2021-08-12       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.